The latest developments in biomarkers predicting response to immunotherapy.
Giandomenico RovielloMelissa BersanelliMartina CatalanoPublished in: Immunotherapy (2022)
Tweetable abstract Biomarkers predicting response to immune checkpoint inhibitors can facilitate the selection of patients who benefit from immunotherapy, avoiding rapid disease progression in nonresponders and needless toxicity.
Keyphrases